IFNA2 and pulmonary arterial hypertension: Because of the 2 documented cases of patients with PAH due to therapy with IFNα2 where PAH was reversible half a year after termination of IFNα2 [3,4] we attempted to terminate sildenafil under control of hemodynamic monitoring.